NICE says Novartis' migraine drug Aimovig too costly for NHS - PharmaTimes https://t.co/EO4opjyQ9K
— IDRO (@IDROOhio) January 11, 2019
from Twitter https://twitter.com/IDROOhio
January 11, 2019 at 12:07PM
Friday, January 11, 2019
NICE says Novartis' migraine drug Aimovig too costly for NHS - PharmaTimes https://t.co/EO4opjyQ9K
from Twitter https://twitter.com/IDROOhio
January 11, 2019 at 12:07PM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment